Fundraising FoxAphelion Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Laplace Interventionallaplaceint.cominSeries C · Mar 2025 · $22M
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation.
HealthtechMedical DevicesPlymouth, US
Ramji Iyer(Executive Officer, Director)in
BoardJenny H. Barba(Director)Todd Mortier(Director)Colin Morrison(Director)
Co-investorsFeatures Capital Holdingsgener8torShangBay Capital LLCUnorthodox VenturesAphelion CardeationEngage Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.